Table 4

Unadjusted hazard ratio (HR) and 95% CI for developing cardiovascular diseases among breast cancer (BC) patients compared to controls

ConditionUnadjusted HR [95% CI]
BC patients vs. controls
Ischaemic heart disease1.08 [0.97–1.20]
Pulmonary embolism3.00 [2.51–3.59]
Atrial fibrillation1.53 [1.38–1.70]
Other cardiac arrhythmias1.43 [1.27–1.61]
Heart failure1.93 [1.33–2.80]
Peripheral vascular disease1.08 [0.86–1.35]
Hypertensive heart disease1.79 [1.67–1.91]
Heart valve disease2.02 [1.79–2.27]
ConditionUnadjusted HR [95% CI]
BC patients vs. controls
Ischaemic heart disease1.08 [0.97–1.20]
Pulmonary embolism3.00 [2.51–3.59]
Atrial fibrillation1.53 [1.38–1.70]
Other cardiac arrhythmias1.43 [1.27–1.61]
Heart failure1.93 [1.33–2.80]
Peripheral vascular disease1.08 [0.86–1.35]
Hypertensive heart disease1.79 [1.67–1.91]
Heart valve disease2.02 [1.79–2.27]
Table 4

Unadjusted hazard ratio (HR) and 95% CI for developing cardiovascular diseases among breast cancer (BC) patients compared to controls

ConditionUnadjusted HR [95% CI]
BC patients vs. controls
Ischaemic heart disease1.08 [0.97–1.20]
Pulmonary embolism3.00 [2.51–3.59]
Atrial fibrillation1.53 [1.38–1.70]
Other cardiac arrhythmias1.43 [1.27–1.61]
Heart failure1.93 [1.33–2.80]
Peripheral vascular disease1.08 [0.86–1.35]
Hypertensive heart disease1.79 [1.67–1.91]
Heart valve disease2.02 [1.79–2.27]
ConditionUnadjusted HR [95% CI]
BC patients vs. controls
Ischaemic heart disease1.08 [0.97–1.20]
Pulmonary embolism3.00 [2.51–3.59]
Atrial fibrillation1.53 [1.38–1.70]
Other cardiac arrhythmias1.43 [1.27–1.61]
Heart failure1.93 [1.33–2.80]
Peripheral vascular disease1.08 [0.86–1.35]
Hypertensive heart disease1.79 [1.67–1.91]
Heart valve disease2.02 [1.79–2.27]
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close